drugset / Trial / NCT03937518

Strontium Ranelate and KOA

NCT03937518

Completed 30 enrolled Mansoura University
RandomizedSequentialOpen-labelTreatment

Summary

The present study was carried out on thirty patients with primary knee osteoarthritis. Patients were recruited from Rheumatology and Rehabilitation Outpatient Clinic at Mansoura University Hospi Patients were divided into two groups: Group 1: included 15 patients who received oral strontium ranelate and physiotherapy program. The age of the patients ranged from 50 to 62 years, they were 11 females and 4 males. Group 2: included 15 patients who received physiotherapy program. The age of the patients ranged from 50 to 62 years, they were 12 females and 3 males. Written consent was obtained from each participant sharing in the study. This study was approved by the institution research board of faculty of medicine, Mansoura University, code: MS/15.10.08. Inclusion

Timeline

Start
2018-07-01
Primary completion
2019-07-01
Completion
2020-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Strontium Ranelate Small molecule 2 g Oral

Indications